UK +44 (0)1865 849841
Malaysia +603 2779 0098

Research and Advances in Synthetic Biology

Synthetic biology is one of the most promising areas of modern science. Predicted to be worth $37.21bn globally by 2022, there is a wealth of potential for developments in the healthcare and plant industries. Interviews with leading experts in the field reveal not only the scope of this exciting field of research, but what first drew them to synthetic biology.

Read More

In vitro Modelling of the Human Upper Digestive Tract

Artificial digestive systems are increasingly used as a relevant alternative to in vivo studies for ethical, technical, regulatory and cost reasons. For more than 20 years, CIDAM, from the University of Auvergne in France, has been developing platforms such as the artificial digestion associating dissolution apparatus, mastication simulator, gastric and small intestinal models, large intestinal systems and intestinal cells in culture.

Read More

Enabling Simultaneous Label-Free Sensing in Microfluidics

Microfluidics is a rapidly developing area of research and scientists are continually discovering the wide range of possibilities the technology can provide. Carolyn Ren is one such scientist. We spoke to Carolyn about her research around droplet microfluidics and how it enables high throughput screening analysis by utilising nanolitre-sized drops as mobilised test tubes.

Read More

Agricultural Science: Reaching Out to the Curious Consumer

The public overwhelmingly trusts farmers and scientists; they just don’t trust farming or science. This seemingly paradoxical statement stems from an appreciation of the raw potential and critical roles of the professions, but a mistrust of the products they generate.

Read More

Exploring the microbiome in the agricultural industry

‘Microbiome’ has become somewhat of a buzzword within science. There have always been ‘live and active cultures’ in your yogurt, then they were in your dog food and recently doctors started to prescribe probiotics to improve human health and cure some diseases. Now they are helping plants.

Read More

Synthetic Biology and Cancer Treatment: Bottlenecks to Translation

Karmella Haynes, at the Arizona State University, is one of the first synthetic biologists to engineer chromatin. It is a development that could ultimately treat diseases like cancer, through enabling large-scale changes in gene expression.

Read More

How to get Funding for Your Human Microbiome Startup

The vast amount of research into the human microbiome is attracting new companies to the field and the race to translate scientific data into viable products has begun. Financial interest in the microbiome is at an all-time high, giving many scientists the opportunity to start their own business as product development or service companies.

Read More

Development of ecosystems for precision medicine

The genomic and post-genomic age promises much for clinical medicine, largely because we can now comprehensively sequence genomic DNA to identify polymorphisms, patterns and mutations. We can also measure gene expression routinely and systematically and with high sensitivity measure the amounts of proteins produced.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.